Lyrica Sales Data

Rank 18 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Lyrica U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 18 2.82% 1.10%
Q3 2013 18 (1) 6.13% -6.03%
Q2 2013 19 3.53% 3.09%
Q1 2013 19 (2) 8.10% 0.29%
Q4 2012 21 2.36% 2.17%
Q3 2012 21 (7) 9.94% 2.12%
Q2 2012 28 -0.78% -0.45%
Q1 2012 28 (3) 6.04% -2.02%
Q4 2011 31 (2) 1.23% 1.25%
Q3 2011 29 -2.94% -2.10%
Q2 2011 29 (1) 0.72% 0.74%
Q1 2011 30

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
October 28, 2013Lyrica May Ease Pain for Depressed Fibromyalgia Patients
May 4, 2012Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
April 29, 2009Common Drug Eases Restless Legs Syndrome

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web4)